WebNovacyt, founded in 2006, by an experimented team coming from biotech and industrial companies, is active in developing, manufacturing and marketing advanced and innovative solutions for cytology. Use the CB Insights Platform to explore Novacyt's full profile. ... Who are the investors of Novacyt? Investors of Novacyt include Wilco. WebJun 30, 2024 · Novacyt SA Graham Mullis, Chief Executive Officer James McCarthy, Chief Financial Officer +44 (0)1276 600081 SP Angel Corporate Finance LLP (Nominated Adviser and Broker) Matthew Johnson / Charlie Bouverat (Corporate Finance) Vadim Alexandre / Rob Rees (Corporate Broking) +44 (0)20 3470 0470 Numis Securities Limited (Joint Broker)
NOVACYT : Press releases NYZ FR0010397232 MarketScreener
WebMar 24, 2024 · Investor Relations Novacyt SA NCYT Ownership Morningstar Rating Rating as of Mar 24, 2024 Quote Chart Stock Analysis News Price vs Fair Value ... WebPlease get in touch using the details below. Alternatively, use the direct contact form below. We’re looking forward to hearing from you Mandy Cowling Corporate & Investor Relations … Advisor and Investor Contacts; AIM Rule 26 information; Corporate Governance; Our … Company York House, School Lane, Chandlers Ford, Eastleigh, SO53 4DG … cso shipping
NOVACYT : Press releases NYZ FR0010397232 MarketScreener
WebFeb 10, 2024 · Investor Relations Novacyt SA ALNOV Ownership Morningstar Rating Rating as of Feb 10, 2024 Quote Chart Stock Analysis News Price vs Fair Value ... WebThe Novacyt Group is a rapidly growing, international diagnostics business generating an increasing portfolio of in vitro and molecular diagnostic tests. Its core strengths lie in … WebNOVACYT has raised a total of $37.8M in funding over 7 rounds. Their latest funding was raised on May 30, 2024 from a Post-IPO Debt round. NOVACYT is registered under the … ealing camera club